The Food and Drug Administration (FDA) in the United States, along with health authorities in Australia, have raised concerns over a commonly prescribed asthma medication, known to have potentially severe neuropsychiatric side effects. This drug, often sold under the brand name Singulair and containing the active ingredient montelukast, has been associated with a range of adverse events, including suicidal thoughts and behaviors, particularly in children and young adults. Despite these concerns, the medication continues to be widely used.
Reports in Australia have linked montelukast to several tragic cases, including the suicides of young individuals and hundreds of other medical incidents. This has led to calls for more stringent warnings on the drug’s packaging. The Therapeutic Goods Administration (TGA) and the Pharmaceutical Society of Australia are contemplating enhanced product information and labeling to better inform consumers about the risks associated with montelukast. Over the past decade, at least 200 adverse events related to montelukast have been reported to the TGA, including numerous instances of suicidal ideation and psychiatric disorders, affecting even children as young as two.
Despite the known risks, montelukast remains a popular treatment for asthma in children due to its ease of administration compared to inhalers. The European Medicines Agency and the FDA have taken steps to ensure that these medications carry explicit warnings about the potential neuropsychiatric effects. However, there is concern that not enough is being done to inform patients and their families about these risks, as evidenced by the experiences of Australian families whose children suffered severely after taking montelukast.
The ongoing situation with montelukast raises significant legal and health concerns. Individuals who have suffered from the severe side effects of this medication might consider legal action. In such cases, a product liability lawsuit could be appropriate. These lawsuits typically require the claimant to demonstrate that the medication caused harm due to being inherently dangerous or having inadequate warnings about its risks.
Navigating a product liability lawsuit can be intricate, requiring expertise in various legal procedures. Each stage, from evidence collection to representation in court, is crucial. An experienced attorney can provide invaluable assistance, ensuring that the victim’s rights are upheld and their case is effectively presented. Potential damages in such a lawsuit could include compensation for medical expenses, pain and suffering, lost income, and in some cases, punitive damages aimed at preventing future negligence.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
For those affected by the adverse effects of montelukast, seeking legal counsel is an important step. Parker Waichman LLP, a national law firm specializing in product injury cases, offers free consultations to victims exploring their legal options. By contacting 1-800-YOUR-LAWYER (1-800-968-7529), individuals can receive guidance and support in navigating the complexities of a product liability lawsuit. The firm’s experienced attorneys are committed to ensuring that victims receive the justice and compensation they deserve.
Regardless of your location or where your injury occurred, our nationwide personal injury law firm is ready to assist you.
.svg){kind=small}
.avif)
.avif)